Cambridge Investment Research Advisors, Inc. - NEWLINK GENETICS CORP ownership

NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 3 filers reported holding NEWLINK GENETICS CORP in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of NEWLINK GENETICS CORP
ValueSharesWeighting
Q4 2019$33,000
+94.1%
13,033
+19.4%
0.00%
Q4 2018$17,000
-56.4%
10,918
-32.9%
0.00%
Q3 2018$39,000
-49.4%
16,2810.0%0.00%
-100.0%
Q2 2018$77,000
-6.1%
16,281
+43.4%
0.00%0.0%
Q1 2018$82,00011,3520.00%
Other shareholders
NEWLINK GENETICS CORP shareholders Q1 2020
NameSharesValueWeighting ↓
NORTHWEST WEALTH MANAGEMENT, LLC 54,282$553,0000.77%
Redmile Group, LLC 1,248,700$12,712,0000.63%
FT Options LLC 20,796$212,0000.32%
Perceptive Advisors 900,000$9,162,0000.18%
Rhenman & Partners Asset Management AB 100,000$1,018,0000.13%
PDT Partners, LLC 349,981$3,563,0000.12%
Alambic Investment Management, L.P. 105,370$1,073,0000.12%
Endurant Capital Management LP 36,100$367,0000.11%
GSA CAPITAL PARTNERS LLP 132,154$1,345,0000.09%
COLUMBUS CIRCLE INVESTORS 485,848$4,946,0000.08%
View complete list of NEWLINK GENETICS CORP shareholders